InMed Pharmaceuticals (IN.T) has filed clinical trial applications (CTAs) in Austria, Israel and Serbia as part of a phase 2 clinical trial of INM-755, the Company’s cannabinol cream used…
Search Results for: IN.T
InMed Pharmaceutical’s (IN.T) IntegraSyn™ cannabinoid manufacturing approach has achieved a level of 2 grams per liter (g/L), marking a significant milestone for the commercialization of IntegraSyn™. “We are very…
Inmed Pharmaceuticals (IN.T) filed a patent co-operation treaty (PCT) application relating to the potential for cannabinoids to prevent neuron damage associated with glaucoma. The patent application is called “Compositions…
A court of Appeals ruling in Florida’s District Court said three earlier negative rulings on patents Wilan (WIN.T) holds should not have been found, paving the way for the…